Inactivated influenza vaccines are produced every year to fight against the seasonal
epidemics of influenza. Despite the nonoptimal coverage, even in subjects at risk like the …

The search for adjuvants has been stimulated by the need to ensure greater protection
against influenza among subjects who show a reduced immune response to conventional …

The numerous influenza infections that occur every year present a major public health
problem. Influenza vaccines are important for the prevention of the disease; however, their …

​ Summary Globally, infection by seasonal influenza viruses causes 3–5 million cases of
severe illness and 290,000–650,000 respiratory deaths each year. Various influenza …

The use of adjuvants is being explored as a means of improving vaccine immunogenicity.
This is particularly important for the development of vaccines against potential pandemic …

Influenza is a major cause of worldwide morbidity and mortality through frequent seasonal
epidemics and infrequent pandemics. Morbidity and mortality rates from seasonal influenza …

Influenza is one of the most common causes of human morbidity and mortality that is
preventable by vaccination. Immunization with available vaccines provides incomplete …

In spite of current influenza vaccines being immunogenic, evolution of the influenza virus
can reduce efficacy and so influenza remains a major threat to public health. One approach …

Vaccination is universally considered as the principal measure for the control of influenza,
which represents a significant burden worldwide, both from a health-care and a socio …

Influenza is one of the major threats to public health. Current influenza vaccines cannot
provide effective protection against drifted or shifted influenza strains. Researchers have …